Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


New Glyphosate Cancer Study Presented at Third Monsanto Roundup Trial

The nation’s third Monsanto Roundup trial is now underway in California’s Alameda County Superior Court, where a new study linking glyphosate to non-Hodgkin’s lymphoma was entered into evidence for the first time yesterday. Court Agreed to Expedite Monsanto Roundup Trial … Continue reading

Acadia Pharmaceuticals Acknowledges DOJ Probing Nuplazid Marketing Tactics

The U.S. Department of Justice (DOJ) is apparently investigating Nuplazid, the controversial Parkinson’s disease treatment sold by Acadia Pharmaceuticals. DOJ Seeks Nuplazid Marketing Materials According to a recent securities filing, Acadia received a Civil Investigation Demand last September for all documents … Continue reading

Study Suggests Hypophosphatemia May Occur in Over 50% of Injectafer Patients

A recent study suggests that more than half of all patients who receive Injectafer for iron deficiency anemia may develop severe hypophosphatemia, a potentially life-threatening condition caused by low levels of phosphorus in the blood. Injectafer and Iron Deficiency Anemia? … Continue reading

Pfizer Xeljanz Lawsuit Claims Generic Drug Maker Infringed Patent

Pfizer, Inc. recently filed a Xeljanz lawsuit accusing a generic drug maker of infringing on its patents for the blockbuster rheumatoid arthritis (RA) medication. Xeljanz Lawsuit Seeks to Prevent Sales of  Generic Version In February, Ajanta Pharma submitted an Abbreviated … Continue reading

Valsartan Lawsuits Move Forward, as Federal Litigation Sets Status Conference Schedule

Valsartan lawsuits continue to move forward in the U.S. District Court, District of New Jersey, where federal claims stemming from the ongoing generic drug recall are currently undergoing coordinated pretrial proceedings. According to a Case Management Order dated April 2nd, … Continue reading

Minnesota Clergy Sexual Harassment Lawsuit Claims St. Cloud Diocese Ignored Priest’s Misconduct

A new clergy sexual harassment lawsuit claims the Roman Catholic Diocese of St. Cloud, Minnesota failed to address repeated complaints involving one of its priests. This is not the first time the St. Cloud Diocese has been accused of mishandling … Continue reading

3M Combat Arms Earplugs Lawsuits Centralized in Florida Federal Court

All federally filed 3M Combat Arms Earplugs lawsuits have been centralized before a single judge, after the U.S. Judicial Panel on Multidistrict Litigation (JPML) agreed that the growing docket would benefit from coordinated discovery and other pretrial proceedings. In an … Continue reading

FDA Investigating Possible Link Between E-Cigarettes and Seizures

Nearly three dozen people have suffered seizures after vaping, according to a new alert from the U.S. Food & Drug Administration (FDA). Although it’s not clear if there is any direct link between e-cigarettes and seizures, the agency noted that … Continue reading

Defendant Fact Sheet Protocols Established for Bard Polypropylene Hernia Mesh Bellwether Cases

The federal court overseeing hundreds of injury claims involving C.R Bard’s polypropylene hernia mesh products has established protocols governing the handling of Defendant Fact Sheets for all cases included in the litigation’s bellwether trial pool. What is a Defendant Fact … Continue reading

FDA Panel Rejects Ban on Textured Breast Implants Implicated in Rare Cancer

A panel of advisers for the U.S. Food & Drug Administration (FDA) agreed that women should be given better information about the risks associated with breast implants, but refused to back a ban on a specific type of device that … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content